Nonprofit hospital work, GLP-1 use, weight loss drugs, and transcranial stimulation

Program notes:0:40 Transcranial stimulation for ASD1:40 Used evoked potential and quick pulses2:41 Motor cortex associated with speech and language3:27 A model for benefits from GLP-1 use4:27 Discern who would be most likely to develop obesity complications5:27 Target to those more likely to have comorbidity6:10 GLP-1 and AUD7:10 Followed for 26 weeks8:10 Side effects when someone doesn't have obesity8:30 Consultants and nonprofit hospitals9:33 Matched with hospitals that did not use10:33 No benefits related to consultants11:31 Told you what they knew already12:55 End